- Actos Bladder Cancer Class Action Lawsuit Investigation
- Zithromax Z-Pak Azithromycin Class Action Lawsuit Settlement Investigation
- Zoloft & SSRI Antidepressant Birth Defect Class Action Lawsuit Investigation
- Stevens Johnson (SJS) & Toxic Epidermal Necrolysis (TEN) Class Action Lawsuit Investigation
- Unum/UnumProvident Disability Insurance Claim Denial Class Action Lawsuit Investigation
- Metal on Metal Replacement Hip Implant Class Action Lawsuit Investigation
- Mesothelioma Asbestos Class Action Lawsuit Settlement Investigation
- Dilantin Stevens Johnson Syndrome (SJS) Class Action Lawsuit Investigation
- Quinolone Lawsuit: Cipro, Levaquin, Avelox Liver Failure, SJS Class Action Lawsuit Investigation
- Lipitor Diabetes Lawsuit: Lipitor Class Action Lawsuit Investigation
- Testosterone Product Class Action Lawsuit Investigation
- Risperdal Gynecomastia Class Action Lawsuit Investigation
- Xarelto Side Effects Class Action Lawsuit Investigation
- Friday, 27 September 2013 04:00
Mississippi Woman’s Family Sues Fresenius for Heart Attack Death
By Dominic Rivera
Mississippi residents Ethel Rowan and Donna Laurant have filed a product liability lawsuit against Fresenius Medical Care Holdings Inc., alleging that Lynn Sheila Rowan’s sudden cardiac death was caused by Fresenius dialysis products NaturaLyte and GranuFlo. Sheila is the daughter of Ethel and the sister of Donna.
Rowan and Laurant’s lawsuit says that Lynn Sheila received dialysis treatment on or about March 9, 2009, from a Fresenius Medical Care clinic in McComb, Mississippi. The treatment included the use of GranuFlo and/or NaturaLyte.
The following day, Lynn Sheila was travelling on public transportation when she went into cardiac arrest. She was taken to Natchez Regional Medical Center in Natchez, Mississippi, where she was pronounced dead from acute cardiac failure.
Fresenius Medical Care Holdings is the largest division of Fresenius Medical Care AG in Germany. It is the largest dialysis services and products company worldwide. It operates most dialysis centers in the U.S. and supplies its products even to its competitors, including DaVita, DCI, Renal Ventures, among others.
Rowan and Laurant’s lawsuit says that “Defendants knew, should have known, or could have learned through reasonable diligence that GranuFlo and/or NaturaLyte caused and/or was associated with an increased risk of death and serious injuries.”
The Fresenius wrongful death lawsuit further states that “the healthcare providers involved in the treatment provided to the Decedent were not aware and through diligent efforts were not able to discover the risk of serious injury and/or death associated with and/or caused by GranuFlo and/or NaturaLyte.”
Had there been a disclosure of the risks, the lawsuit says that Lynn Sheila would have not purchased nor used the both drugs for her treatment.
The GranuFlo lawsuit says that “neither the product label, packaging, instructions, nor the packages containing the product, provided adequate instructions and/or warnings regarding the use of GranuFlo and/or NaturaLyte.”
The lawsuit even states that Fresenius “intentionally, recklessly and/or negligently advertised, promoted, marketed, sold and distributed GranuFlo and NaturaLyte as being safe for use in dialysis when, in fact, the Defendants had reasons to know, and/or did know, that the products were not safe and caused serious medical problems, and in certain patients, catastrophic, life threatening, injuries.”
An internal memo from Fresenius on November 4, 2011, indicated that Fresenius had knowledge that there was a significant increased risk of cardiac arrest and death during hemodialysis treatments associated with GranuFlo and NaturaLyte.
Unfortunately, the memo came late for Lynn Sheila. Her mother and sister is seeking for compensatory damages, exemplary, and punitive damages together with interest, the costs of the suit and attorneys’ fees, and other relief as the Court may deem just and proper.
The Fresenius wrongful death lawsuit is Ethel C. Rowan and Donna R. Laurant, on behalf of Lynn Sheila Rowan v. Fresenius Medical Care Holding Inc., Case No. 3:13-cv-577 WHB-RHW, in the U.S. District Court for the Southern District of Mississippi.
If you or a loved one were given GranuFlo or NaturaLyte during dialysis and suffered side effects, including death, you may have a GranuFlo legal claim. Find out more about your options at the Kidney Dialysis Heart Attack, GranuFlo and NaturaLyte Recall Class Action Lawsuit Settlement Investigation. After you submit your story, a GranuFlo lawyer will be in touch if you have a case for a claim review.
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement